Reuters logo
BRIEF-Zynerba Pharmaceuticals says estimates that as of Dec. 31 cash and cash equivalents were about $31 mln
January 18, 2017 / 10:55 PM / a year ago

BRIEF-Zynerba Pharmaceuticals says estimates that as of Dec. 31 cash and cash equivalents were about $31 mln

Jan 18 (Reuters) - Zynerba Pharmaceuticals Inc

* Zynerba Pharmaceuticals Inc - estimates that as of December 31, 2016 cash and cash equivalents were approximately $31.0 million Source text - bit.ly/2jp373S Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below